Mental Disorders Drugs Market Research Report by Regional Analysis with forecast upto 2024
A mental disorder can be explained as a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental disorders are very diverse and often unclear in most cases. However, some of the commonly addressed drug classes for the treatment of mental disorders are anxiolytics, antidepressants, and antipsychotics. Some of the common mental disorders affecting millions around the world are depression, schizophrenia, and intellectual disabilities and disorders due to drug abuse.
The most common factor aiding the expansion of the global mental disorders drugs market is the rising incidence of mental disorders. For instance, as per the WHO’s reviewed fact sheet, as of 2016 over 350 million people worldwide are affected by depression, over 60 million people are diagnosed with bipolar disorder, and almost 21 million people around the world have schizophrenia and other psychoses. The incidence is rising and there is less likely for it to subside anytime soon. Governments around the world are thus focusing on development effective treatment and drugs to eliminate the prevalence of mental disorders.
Considering the scenario, the global mental disorders market is poised to surge at an exponential pace between 2016 and 2024. In the report, TMR provides a granular analysis of the various factors supporting the market’s growth and lists down the restraints threatening its expansion. Using Porter’s five forces, the report gauges the bargaining power of suppliers and buyers, degree of competition prevailing in the market, and threat of product substitutes and new entrants. The effect of government policies on the market is analyzed in detail.
Besides these, the report also studies the regional market for mental disorders drugs across North America, Europe, Asia Pacific, and Rest of the World. Factors influencing the market’s growth across these regional segments are studied in detail. In addition, the global mental disorders drugs market has been segmented based on various parameters to help the market participants identify the most lucrative areas in the market. Compiled with exhaustive information, the report thus provides a holistic overview of the global mental disorders market.
Browse full report on Mental Disorders Drugs Market -
Global Mental Disorders Drugs Market: Trends and Opportunities
Factors such as improvement in patient security policies, increasing prevalence of mental disorders, growth in domestic and international investment in research and development on mental medication, and increasing awareness about these conditions are aiding the growth of the global mental disorders market.
Overall, the market has been witnessing lucrative prospects, however, skepticism surrounding the social pressure and stigma often attached with mental disorders and their treatment could restraint the market to an extent. The situation is more critical in case of less developed countries, where medical advancements are yet to penetrate into. Furthermore, inadequate government initiatives could create bottleneck for the market in underdeveloped countries, despite the high prevalence of unmet medical needs.
Nevertheless, rising government spending in the healthcare sector, especially across emerging economies such as India and China, increasing medical tourism in these nations due to the availability of advanced treatments at affordable price, and supportive reimbursement policies will help the expansion of mental disorders drugs market over the course of the forecast period. Besides this, the market is also expected to gain from the launch of novel therapeutics.
Overall, the global mental disorders drugs market can be segmented into antipsychotics, antidepressants, anxiolytics, drugs for adolescent and childhood mental illness, schizophrenia, drugs for the treatment of addiction, and bipolar disease drugs. The report studies in detail the recent developments supporting the market’s growth across these segments.
Global Mental Disorders Drugs Market: Regional Outlook
Regionally, North America dominates the global mental drugs disorders market. The increasing government initiatives, high awareness about mental disorders and available treatments, and better reimbursement policies are supporting growth of the market in North America. In addition, the market is expected to witness lucrative opportunities in Asia Pacific. The expanding healthcare industry and favorable initiatives supporting the growth will help market participants rake high profits in the region.
Global Mental Disorders Drugs Market: Vendor Landscape
The report includes a detailed assessment of the vendor landscape, to study the competition prevailing in the global mental disorders market. Some of the companies profiled are Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Using SWOT analysis, the report studies the strengths and weaknesses of the companies profiled. The analysis also provides insights into the threats and opportunities that the companies will witness over the course of the forecast period.
Request for sample of this report -
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mental Disorders Drugs Market Research Report by Regional Analysis with forecast upto 2024 here
News-ID: 460751 • Views: 229
More Releases from Transparency Market Research - Pharmaceutical
Antithrombin Market Estimated to Flourish by 2025
As per estimates presented in a report by TMR, the demand global antithrombin market will rise at a CAGR of 5.2% for the forecast period of 2017 to 2025. The market for antithrombin is predicted to attract a revenue of US$704.5 mn by the end of 2025 from US$448.2 mn in 2016. The global Antithrombin market is consolidated in nature with a few small-scale vendors that operate in regional markets and
Cancer Vaccines Market - Industrial applications witness fastest growth up to 20 …
Vaccines are medicines that stimulate the immune system of the body to protect against foreign substances. The stimulated immune system destroys foreign bodies and remembers it. Vaccines work on this principle of memorizing foreign particle and prevent infection likely to be caused by this foreign particle when it invades again. Cancer vaccines are medicines categorized as biological response modifiers. These modifiers work by stimulating the immune system to fight against
Bipolar Disorder (BPD) Market - Global Industry Growth and Forecast 2017 - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Otitis Externa Treatment Market - Market Future Growth Opportunities | 2024
Otitis externa causes inflammation of the external ear canal, which is a tube between ear and eardrum. The inflammation is caused due to infection in the ear canal which can be bacterial or fungal origin. Otitis externa is characterized by pain, tenderness, redness, and swelling of the external ear canal. Otitis externa is generally cured within a week, but sometimes it persists for three or more than three months. The
More Releases for Mental
Mental Health 2019
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders or rub elbows with pioneers across the globe. London is all set for an amazing event as PULSUS proudly presents the “World Congress on Mental Health” scheduled on November 13,14, 2019 at London, UK. PULSUS cordially welcome researchers, academicians, students and business professionals in the field
World Congress on Mental Health
London is all set for an amazing event as PULSUS proudly presents the “World Congress on Mental Health” scheduled on November 13,14, 2019 at London, UK. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of Psychiatry from around the world to participate in the upcoming Mental Health 2019. The meeting for this year will revolve around the theme “Intellectual Learning of Mental Health and Psychological Resilience”
Pain and Suffering and Mental Illness
Personal injury cases often involve multiple types of damages that a victim may receive as a part of their compensation when a claim is made. One of the most common forms of damages individuals suffer from and claim for is pain and suffering which includes various forms of emotional distress or even mental illness that require treatment. One article stated that “While a car accident is able to leave physical
Psychiatric and Mental Health Nursing 2019
Psychiatric and Mental Health Nursing 2019 will prove to be a noteworthy event, with this we cherish mental health nursing by embracing the theme, “Fore-fronting nursing care to achieve mental wellness” , and would step forward to provide an opportunity to step in and join our family, as we bring and encourage to join professionals from the following areas of Mental Health, Psychology, Nursing, Physiology, Neurology, Healthcare, Education, Business to
JLF Web Design Supports Employees Mental Wellness
Phoenix, AZ, August, 28 2018 JLF Web Design, is a web marketing company in Phoenix, Arizona and is a proactive supporter of a healthy workplace environment. JLF Web Design is pleased to announce a special relationship with Lifewell Behavioral Wellness. Lifewell Behavioral Wellness is a non-profit integrated healthcare agency providing treatment, services and support for low-income clients diagnosed with mental health issues, and substance abuse disorders. “At JLF Web Design,
High Prevalence of Mental Disorders Boosts Mental Health Software Sales
Mental health software enables behavioral health professionals to choose the best treatment plan for a person suffering from stress, anxiety, depression, addiction etc., based on clinical evidences and patient records. These software also allows users to schedule online appointments and facilitate medical bill payment via mobile devices such as laptops and smartphones. The global mental health software market was valued at US$ 1,971.5 Mn in 2014. North America was the largest